Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Allergy and Immunology

Symptoms, Triggers, and Warning Signs

At a Glance

Systemic mastocytosis causes two types of symptoms: sudden allergic reactions from mast cell chemical release, and organ damage from abnormal mast cell buildup in tissues. Identifying personal triggers like stress, extreme temperatures, or certain medications is critical to prevent severe reactions.

Symptoms of systemic mastocytosis (SM) are notoriously diverse, often affecting multiple parts of the body simultaneously. Because these symptoms can mimic many other conditions, patients frequently face years of misdiagnosis [1]. To better understand your experience, it helps to categorize symptoms into two distinct groups: those caused by the release of chemicals and those caused by the physical buildup of mast cells in your organs [2][3].

1. Mediator-Related Symptoms (The “Chemical Release”)

The most common symptoms in SM occur when mast cells “degranulate,” or release chemical mediators like histamine and tryptase into the bloodstream [2]. These symptoms can happen suddenly.

  • Skin Reactions: The most common sign is urticaria pigmentosa—reddish-brown spots on the skin that may itch or hive when rubbed [4]. Sudden flushing or redness is also frequent.
  • Anaphylaxis: Patients are at a higher risk for severe, life-threatening allergic reactions that require immediate medical attention [2].
  • Digestive Distress: This includes abdominal pain, cramping, and “secretory diarrhea” [5][4].
  • “Brain Fog”: Many patients describe neuropsychiatric symptoms such as difficulty concentrating, memory issues, or sudden mood changes [6][7].
  • Cardiovascular Issues: Sudden drops in blood pressure can lead to lightheadedness, fainting (syncope), or rapid heart rate [2].

Identifying Your Triggers

Mast cells in SM patients are hyper-reactive. Keeping a symptom and trigger diary is an excellent way to identify what causes your mast cells to degranulate. Common everyday triggers include extreme temperatures (hot or cold), physical exertion, stress, and certain foods or alcohol [8].

Medical and Surgical Triggers (Crucial Warning):
SM patients can have severe, life-threatening reactions to common medical and environmental triggers [8]. You must proactively alert all healthcare providers, anesthesiologists, dentists, and pharmacists of your diagnosis. Known high-risk triggers include:

  • Medications: NSAIDs (like ibuprofen or aspirin), opioid analgesics (like morphine or codeine), and certain anesthetics or muscle relaxants used during surgery.
  • Procedures: Radiocontrast dyes used in MRI or CT scans.
  • Environmental: Hymenoptera stings (bee, wasp, hornet, and yellow jacket stings) are a frequent cause of severe anaphylaxis in SM patients [9].

2. Organ Infiltration Symptoms (The “Cellular Burden”)

In some forms of the disease, abnormal mast cells physically accumulate in organs, interfering with their ability to function. These are often referred to as B-findings (high burden) or C-findings (organ damage) [10][11].

  • Bone Pain and Lesions: Mast cell buildup in the bones can lead to deep aching, osteoporosis, or “punched-out” holes in the bone called osteolysis [12][7].
  • Cytopenias: When mast cells crowd the bone marrow, they can lower the production of healthy blood cells, leading to anemia, infections, or bleeding [11][7].
  • Enlarged Organs: Doctors may find an enlarged liver (hepatomegaly) or spleen (splenomegaly) during an exam [11][13].
  • Malabsorption: If mast cells infiltrate the lining of the gut, the body may struggle to absorb nutrients, leading to unexplained weight loss [11].

Common Mimics and Confusion

Because its symptoms are so broad, SM is frequently confused with other conditions [14][15].

  • Mast Cell Activation Syndrome (MCAS): Like SM, MCAS involves chemical release symptoms. However, MCAS does not involve the abnormal buildup of mast cells or the specific KIT D816V mutation found in SM [16][17].
  • Irritable Bowel Syndrome (IBS): Many SM patients are initially told they have IBS due to chronic diarrhea and cramping [18].

Common questions in this guide

What is the difference between chemical release and organ infiltration symptoms in systemic mastocytosis?
Chemical release symptoms occur when mast cells suddenly release substances like histamine, causing flushing, diarrhea, or anaphylaxis. Organ infiltration symptoms develop when abnormal mast cells physically build up in organs like the bones, liver, or spleen, potentially causing damage over time.
What are common triggers that cause mast cell reactions?
Everyday triggers can include extreme temperatures, physical exertion, stress, and certain foods or alcohol. Medical triggers such as NSAIDs, opioids, radiocontrast dyes, and bee stings can cause severe, life-threatening reactions.
How does systemic mastocytosis affect the bones?
Abnormal mast cells can build up in the bone marrow, leading to deep bone pain, osteoporosis, or punched-out lesions called osteolysis. This crowding can also lower the production of healthy blood cells, causing anemia, bleeding, or infections.
Can systemic mastocytosis cause brain fog?
Yes, many patients experience neuropsychiatric symptoms often described as brain fog. This can include difficulty concentrating, memory issues, or sudden mood changes due to the sudden release of mast cell chemicals.
Why is systemic mastocytosis often confused with Irritable Bowel Syndrome (IBS)?
Systemic mastocytosis frequently causes severe digestive issues like abdominal pain, cramping, and chronic diarrhea. Because these symptoms are very similar to Irritable Bowel Syndrome, patients may be misdiagnosed for years before the true cause is identified.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How can we determine if my gastrointestinal symptoms are caused by chemical release or by physical mast cell infiltration?
  2. 2.What specific 'B-findings' or 'C-findings' have you identified in my case, and how do they impact my treatment strategy?
  3. 3.Is my current level of 'brain fog' or fatigue typical for my subtype, or should we look for other contributing factors?
  4. 4.Since my bone marrow biopsy, have there been any signs of 'cytopenias' (low blood counts) that I should be monitoring?
  5. 5.Should I have a baseline bone density scan to check for bone lesions or osteoporosis related to my condition?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis.

    Bulai Livideanu C, Apoil PA, Lepage B, et al.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2016; (46(1)):133-41 doi:10.1111/cea.12627.

    PMID: 26767494
  2. 2

    Pathogenesis and Pathology of Mastocytosis.

    Metcalfe DD, Mekori YA

    Annual review of pathology 2017; (12()):487-514 doi:10.1146/annurev-pathol-052016-100312.

    PMID: 28135563
  3. 3

    Patient-reported outcomes among patients with systemic mastocytosis in routine clinical practice: Results of the TouchStone SM Patient Survey.

    Mesa RA, Sullivan EM, Dubinski D, et al.

    Cancer 2022; (128(20)):3691-3699 doi:10.1002/cncr.34420.

    PMID: 35996873
  4. 4

    c-KIT-Positive Fatal Diffuse Cutaneous Mastocytosis With Systemic Manifestations in a Neonate.

    Chaudhary N, Shapiro N, Bhutada A, Rastogi S

    Journal of pediatric hematology/oncology 2019; (41(5)):e338-e340 doi:10.1097/MPH.0000000000001271.

    PMID: 30067557
  5. 5

    Insights in Anaphylaxis and Clonal Mast Cell Disorders.

    González-de-Olano D, Álvarez-Twose I

    Frontiers in immunology 2017; (8()):792 doi:10.3389/fimmu.2017.00792.

    PMID: 28740494
  6. 6

    H1-antihistamines for primary mast cell activation syndromes: a systematic review.

    Nurmatov UB, Rhatigan E, Simons FE, Sheikh A

    Allergy 2015; (70(9)):1052-61 doi:10.1111/all.12672.

    PMID: 26095756
  7. 7

    Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms.

    Tashi T, Deininger MW

    Immunology and allergy clinics of North America 2023; (43(4)):723-741 doi:10.1016/j.iac.2023.04.009.

    PMID: 37758409
  8. 8

    Management of indolent mastocytosis and mast cell activation syndrome: A clinical yardstick.

    Akin C, Butterfield JH, Castells M, Lyons JJ

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2025; (135(4)):466-477 doi:10.1016/j.anai.2025.06.032.

    PMID: 40592381
  9. 9

    Bone Marrow Mastocytosis: A Diagnostic Challenge.

    Zanotti R, Tanasi I, Bernardelli A, et al.

    Journal of clinical medicine 2021; (10(7)) doi:10.3390/jcm10071420.

    PMID: 33915965
  10. 10

    Relevant updates in systemic mastocytosis.

    Coltoff A, Mascarenhas J

    Leukemia research 2019; (81()):10-18 doi:10.1016/j.leukres.2019.04.001.

    PMID: 30978435
  11. 11

    Mastocytosis and related entities: a practical roadmap.

    Beyens M, Elst J, van der Poorten ML, et al.

    Acta clinica Belgica 2023; (78(4)):325-335 doi:10.1080/17843286.2022.2137631.

    PMID: 36259506
  12. 12

    Management of skeletal-related events and fracture prevention in systemic mastocytosis.

    Lunn EM, Lacount S, Greene LW, Asadipooya K

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2026; (37(3)):605-619 doi:10.1007/s00198-025-07726-4.

    PMID: 41263967
  13. 13

    Acute aleukemic mast cell leukemia: Report of a case and review of the literature.

    Galura GM, Cherukuri SV, Hakim N, et al.

    Leukemia research reports 2020; (14()):100230 doi:10.1016/j.lrr.2020.100230.

    PMID: 33318926
  14. 14

    High-sensitivity KIT D816V variation analysis by droplet digital polymerase chain reaction: The reference laboratory perspective.

    Shean RC, Hellwig S, Saadalla A, et al.

    American journal of clinical pathology 2025; (164(2)):145-149 doi:10.1093/ajcp/aqaf008.

    PMID: 40036308
  15. 15

    Mastocytosis: Imaging Spectrum and Diagnostic Insights.

    Khot R, Diab M, Jing JM, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2026; (46(1)):e250075 doi:10.1148/rg.250075.

    PMID: 41433193
  16. 16

    Idiopathic mast cell activation syndrome is more often suspected than diagnosed-A prospective real-life study.

    Buttgereit T, Gu S, Carneiro-Leão L, et al.

    Allergy 2022; (77(9)):2794-2802 doi:10.1111/all.15304.

    PMID: 35364617
  17. 17

    Successful treatment of idiopathic mast cell activation syndrome with low-dose Omalizumab.

    Berry R, Hollingsworth P, Lucas M

    Clinical & translational immunology 2019; (8(10)):e01075 doi:10.1002/cti2.1075.

    PMID: 31576204
  18. 18

    Mast Cell Activation Syndrome: A Primer for the Gastroenterologist.

    Weinstock LB, Pace LA, Rezaie A, et al.

    Digestive diseases and sciences 2021; (66(4)):965-982 doi:10.1007/s10620-020-06264-9.

    PMID: 32328892

This page explains systemic mastocytosis symptoms and triggers for educational purposes only. Always consult your allergist or hematologist before changing medications or attempting to manage severe allergic reactions.

Get notified when new evidence is published on Systemic mastocytosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.